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Abstract
Background: In situ hybridization (ISH) is a powerful method for visualizing gene expression
patterns at the organismal level with cellular resolution. When automated, it is capable of
determining the expression of a large number of genes.
Results: The expression patterns of 662 genes that encode enzymes were determined by ISH in
the mid-gestation mouse embryo, a stage that models the complexity of the adult organism. Forty-
five percent of transcripts encoding metabolic enzymes (n = 297) showed a regional expression
pattern. A similar percentage was found for the 190 kinases that were also analyzed. Many mRNAs
encoding glycolytic and TCA cycle enzymes exhibited a characteristic expression pattern. The
annotated expression patterns were deposited on the Genepaint database and are retrievable by
user-defined queries including gene name and sites of expression.
Conclusion: The 662 expression patterns discussed here comprised gene products with activities
associated with catalysis. Preliminary analysis of these data revealed that a significant number of
genes encoding housekeeping functions such as biosynthesis and catabolism were expressed
regionally, so they could be used as tissue-specific gene markers. We found no difference in tissue
specificity between mRNAs encoding housekeeping functions and those encoding components of
signal transduction pathways, as exemplified by the kinases.
Background
When and where genes are expressed provides useful
information about their function. This view forms the
basis of several genome-scale projects that attempt the sys-
tematic localization of mRNAs and/or proteins expressed
in tissues and cells [1,2]. When the products of genes
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remain within the cells that transcribe and translate them,
localizing mRNAs is especially informative. Cell-autono-
mously acting proteins include transcription factors,
transmembrane proteins and also the majority of meta-
bolic enzymes. Although the expression patterns of many
genes that encode enzymes have been determined on a
gene-by-gene basis, the systematic effort used in the
present study stands out because it not only provides a sig-
nificant coverage of enzymes encoded in the genome but
is conducted in a standardized fashion. In addition,
expression sites are annotated and images are made acces-
sible on a public website [3,4].
The biochemistry of glycolytic and TCA cycle enzymes has
been extensively studied, but the expression patterns of
the genes encoding these enzymes in a multicellular
organism have not yet been systematically examined.
Genes encoding glycolytic and TCA cycle enzymes are a
particularly attractive target for a systematic analysis of
expression patterns because their products form path-
ways. The glycolytic pathway is located in the cytosol and
consists of a sequence of ten steps catalyzed by 22 differ-
ent gene products, some of which are isozymes. The prod-
uct of glycolysis (pyruvate) serves as starting material for
the mitochondrial TCA cycle. The TCA cycle comprises
eight distinct steps involving 20 gene products, several of
which form multisubunit complexes.
While glycolysis and the TCA cycle illustrate pathways
characterized by sequences of catalytic reactions, mamma-
lian carbonic anhydrases (CAs) exemplify a single protein
family, all the members of which catalyze the interconver-
sion of carbon dioxide and bicarbonate [5]. Notably, 13
of the 16 CAs are catalytically active while the remaining
three are CA-related polypeptides (CA-RP). These have
high sequence homology to CAs but seem to lack enzy-
matic activity [6,7]. The three CA-RPs (CA VIII, X and XI)
owe their putative lack of CA activity to substitutions of
one or more active site residues [6,7]. CAs are located in
different subcellular compartments: CA I, II, III, VII [5,8]
and XIII are cytosolic enzymes [9]. CA IV [10] and XV [11]
are anchored to the plasma membrane, while CA IX, XII
[12] and XIV [13] are transmembrane proteins. Both CA
VA and CA VB encode mitochondrial enzymes [14,15],
while CA VI is a secreted protein [16,17]. CAs participate
in a variety of physiological processes including pH regu-
lation, CO2 and HCO3- transport, ion transport, water
and electrolyte balance, ureagenesis, gluconeogenesis and
lipogenesis (reviewed in [5,18]).
We previously developed methods for determining the
spatial expression patterns of genes by in situ hybridiza-
tion (ISH) on a transcriptome-wide scale ([3,19]; see
also[4] and [20]). Here we report the expression patterns
of 662 genes that encode either catalytic or regulatory sub-
units of enzymes, representing a quarter of the 2700 gene
products with catalysis-associated activity. Gene expres-
sion was analyzed on serially sectioned, stage E14.5
mouse embryos. The mid-gestation embryo provides an
overview of the entire organism showing well-differenti-
ated organs and tissues resembling those of the adult in
their basic design. One can readily capture all organs in a
set of 24 serial sections through such an embryo. The
genetic programs underlying e.g. growth, terminal differ-
entiation, cell migration and apoptosis are still develop-
ing at E14.5, so it is possible to study a wide range of
biological processes [21].
This report has three aims. It provides a listing and a first-
pass analysis of the expression of all 662 genes; it com-
pares the expression patterns of glycolytic and TCA cycle
genes; and it compares the expression patterns of 15 of the
16 known CAs in order to illustrate the astonishing diver-
sity of expression patterns exhibited by members of a sin-
gle multigene family.
Results and discussion
Expression patterns of mouse genes encoding proteins 
with catalytic activity
Under its "Molecular Function" category, Gene Ontology
lists approximately 2700 gene products that exhibit activ-
ity associated with catalysis [22]. We have determined the
expression patterns of 662 of the 2700 mRNAs in E14.5
mouse embryos using robotic ISH. The expression pattern
of each gene was based on the analysis of ~ 24 sagittal sec-
tions, 25 μm thick and 150 μm apart. The products of the
662 genes included transferases, oxidoreductases, ligases
and other enzymes (Table 1). Genes were selected on the
basis of three not mutually exclusive criteria: (1) the genes
scored as 'present' in a duplicate Affymetrix microarray
chip (MA) hybridized with mRNA from E14.5 mouse
embryos (MA data were deposited at NCBI GEO under
accession number GSE6081); (2) all gene products encod-
ing glycolytic and TCA cycle enzymes were selected; (3)
for kinases, the intensity of the MA signal was ranked by
the raw numerical value, and the 190 most strongly-
expressed transcripts were selected.
All but three of the 662 genes analyzed can be classified
into a particular Gene Ontology (GO) subcategory of
enzymatic activity (Table 1). On the basis of their domain
structures, Dip2a, Echdc1 and Echdc2 have inferred cata-
lytic activities. The ISH data set used here represents
between 18 and 77% of the GO subcategories. Also, one
third of the murine kinome was represented by 190
kinases, a subcategory of transferases [23].
Of the 662 genes, 594 (90%) were expressed in one or
more embryonic tissues (Table 2), while only 68 (10%)
were not detected. One hundred and six (16%) wereBMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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expressed ubiquitously (U); 297 (45%) were expressed
regionally (R). One hundred and ninety-two (29%) tran-
scripts fell into the "ubiquitous with pattern" (UWP) cat-
egory (defined as an expression pattern in which
transcripts are detected in most tissues and cells but
expression is elevated in subregions within tissues). A sim-
ilar distribution was observed when kinases only were
scored; 45% of the kinases were regionally expressed and
~ 30% showed UWP expression. Thus, metabolic
enzymes, often viewed as housekeeping proteins that
should be expressed ubiquitously, and kinases, involved
in signal transduction and hence expected to exhibit tis-
sue-specific expression, showed similar degrees of region-
alization of expression. Additional file 1 lists all 662 genes
analyzed and provides information about their overall
expression type using the nomenclature of Table 2 and
complemented by a numerical score for expression level
(not detected, or levels 1 [weak], 2 [medium] and 3
[strong]).
All ISH data generated for this study are fully accessible at
the Genepaint database [4]. Data can be retrieved using
gene name, gene symbol (provided in Additional file 1),
accession number, Entrez Gene ID or Genepaint set ID (a
specific accession number, unique to each data set depos-
ited in the Genepaint database) [3,4]. Many of the expres-
sion patterns of the 662 genes are annotated in
approximately 100 different tissues. As a result, patterns
can be queried by site of expression. For example, genes
expressed in liver and heart can be identified using the
structure selection tool of the Genepaint database [4].
Images of individual sections of each set retrieved can be
inspected using image viewers that are integrated into the
database. For additional instructions on how to access
Genepaint data see references [3,4,19].
Through our detailed analysis of the expression patterns,
we identified numerous genes with tissue-specific expres-
sion, which can be used as molecular markers at E14.5
(Fig. 1A–Q). Lysyl oxidase-like 3 (Loxl3, Fig. 1C) is
expressed in cartilage. This is consistent with earlier
reports that implicated this enzyme in the biogenesis of
connective tissues [24,25]. Acetyl-Coenzyme A synthetase
2 (AMP forming)-like (Acas2l) is strongly expressed in the
ventricular zone of the developing nervous system (Fig.
1F, G) and in liver (Genepaint set ID MH1439, section
4C). This enzyme ligates acetate to coenzyme A to pro-
duce acetyl-CoA, a molecule essential in various meta-
bolic pathways. Accordingly, Acas2l is reported to be
strongly expressed in metabolically active tissues in adult
mice [26]. Interestingly, however, it is not seen in adult
liver [26]; apart from the CNS, liver is the only site at
which Acas2l is expressed in the embryo. Expression in
the strongly proliferating CNS ventricular zone may
reflect the energy requirements of dividing cells. Carbox-
ypeptidase N polypeptide 1 (Cpn1, Fig. 1H) exclusively
marks the digestive system with strong expression in liver,
intestine, pancreas and stomach. A previous study reports
Cpn1 expression in embryos as early as E8.5 [27]. The ISH
data in [25] also show expression at E10.5 and E13.5 in
erythroid progenitor cells in the embryonic liver and at
E16.5 in hepatocytes.
The subsequent sections of this report focus on glycolysis
and TCA cycle genes. The salient features of the expression
pattern are briefly described for each gene and, where war-
ranted, patterns are related to those of other genes in the
same pathway. Individual images of expression patterns
are not provided in this paper since there are more than
500 images for the TCA cycle genes alone. Instead, the sec-
tion below provides the Genepaint set ID and the section
Table 2: Frequency of gene expression patterns
ISH expression pattern Number of cases
Ubiquitous (U) 106
Regional (R) 297
Ubiquitous with pattern (UWP) 191
Not detected (N) 68
Table 1: Classification of genes analyzed by type of catalytic activity
GO term name 
(subcategory level 2)
Total number of GO gene 
products
Number of GO gene product 
represented in ISH data set
Percentage of GO covered by 
ISH data set
Hydrolase activity 1011 188 18%
Transferase activity 908 261 28%
Oxidoreductase activity 433 114 26%
Ligase activity 146 62 42%
Lyase activity 72 56 77%
Helicase activity 59 4 6%
Isomerase activity 52 18 34%
Peroxidase activity 27 10 37%
RNA editase activity 4 3 75%
Genes with inferred activity 3BMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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Examples of tissue-specific molecular markers in the E14.5 mouse embryo Figure 1
Examples of tissue-specific molecular markers in the E14.5 mouse embryo. A and B. Prostaglandin D2 synthase 
(brain) (Ptgds) (Genepaint set ID HD33, image 2C) expression is exclusive to the meninges (me), choroid plexi (cp, A) and 
gonads (g, B). C. Lysyl oxidase-like 3 (Lox13) (MH1813, 4A) is exclusively expressed in cartilage (ca). D and E. Ribonuclease T2 
(Rnaset2) (MH1633, 1A, 5A) is a suitable marker for lens (le, D) and choroid plexi (cp, E). F and G. Acetyl-Coenzyme A synthetase 
2 (AMP forming)-like (Acas2l) (MH1439, 4C, 4B) marks the ventricular zones of the nervous system (vz, F), including that of the 
spinal cord (sp, G), and liver (not shown). H. The gene Carboxypeptidase N polypeptide 1 (Cpn1) (MH1654, 5B) marks liver (li), 
pancreas (pa) and stomach (so). I and J. Expression of Alcohol dehydrogenase 1 (class I) (Adh1) (MH1744, 3D) is seen in adrenal 
gland (a, I), lung mesenchyme (lu, I) and nasal epithelium (n, J). K and L. Phospholipase A2 (Pla2g2f) (MH1625, 3A) expression is 
restricted to the lung (lu, K) and the adrenal gland (a, L). M and N. Glucokinase (Gck) (MH1608, 4C) is exclusive to the ventro-
medial nucleus of the hypothalamus (vt), preoptic area, anterior pituitary (pi, M) and pancreas (pa, N), O – Q. Expression of 
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number leading to the correct image on the Genepaint
database [4]. Genepaint set IDs (e.g. MH2297) can be
entered in the search field of the homepage [4]. Clicking
on the "go" button produces the "results" page on which
the "set viewer" link is available. The appropriate section
link (e.g. section 3A) can be selected in the image direc-
tory, generating a thumbnail of the section. This thumb-
nail can be magnified by clicking any one of three viewer
buttons labelled "HTML", "Applet" or "Plugin".
Expression patterns of glycolytic pathway enzymes
We found that many of the glycolytic and TCA cycle genes
exhibited a recurrent pattern of expression, which we
denoted the "Stereotypical Energy Metabolism Pattern"
(SEMP). The SEMP, an example of which is shown in Fig.
2, is characterized by the following features. First, expres-
sion is seen in a set of 22 "signature tissues" (listed in the
header of matrices A and B in Fig. 3) and expression
strength is usually not constant across the signature tissues
but varies among them. Second, expression is not detected
in axial cartilage and long bones. The matrix shown in Fig.
3A is a schematic diagram of the expression of all glyco-
lytic pathway components assessed in signature tissues,
axial and limb cartilage. It can be seen that with the excep-
tion of aldolases (see below), at least one gene exhibits a
SEMP (highlighted in bold in the Gene Symbol column of
Fig. 3A) for each step in glycolysis. 9 of the 22 genes
involved in glycolysis show a SEMP.
Hexokinase 1, Hk1 (Genepaint set ID MH2297, section 3A)
This gene is broadly expressed throughout the embryo but
signal strength is elevated in the superior and inferior col-
liculi, spinal chord, dorsal root- and cranial ganglia, and
in the telencephalon.
Hexokinase 2, Hk2 (MH1148, 3A)
The expression pattern in the nervous system strongly
resembles that of Hk1, but in contrast to hexokinase 1, Hk2
is only weakly expressed outside the nervous system
except in the epithelial component of the lung.
Hexokinase 3, Hk3 (MH 2298, 3A)
Low and ubiquitous expression characterizes this gene,
with some notable exceptions such as the cranial- and
dorsal root ganglia (3D), which exhibit strong expression
in scattered neurons. Expression is markedly elevated in
the perichondrium of the axial skeleton (3B).
Hexokinase 4, Gck (MH1608)
Expression is observed in the anterior pituitary, in the ven-
tromedial nucleus of the hypothalamus and in the preop-
tic area (4C). It is also seen the locus coeruleus (3A), the
major site of noradrenalin production in the mammalian
brain. Outside the CNS, Gck mRNA is seen in the primor-
dium of the pancreas (4C). Among the four genes encod-
ing the allosterically regulated hexokinases, Gck  stands
out because of its spatially restricted expression pattern.
Glucose phosphate isomerase 1, Gpi1 (MH1105, 3A)
This gene is expressed in almost every part of the embryo
and very strongly in some tissues. Gpi1 expression is par-
ticularly strong in the ventricular zone of the developing
neocortex and spinal cord, in the motor column along the
spinal cord, in dorsal root and cranial ganglia and in the
cranial nerve nuclei. The retina (1B), olfactory epithelium,
heart, muscles, liver and whisker follicles express Gpi1.
Like Gck, Gpi1 is expressed in the locus coeruleus and in
many midbrain neurons (2C).
Phosphofructokinase muscle, Pfkm (MH1237, 2D and 4B)
Generally, this gene is weakly expressed in many regions
of the nervous system. The most striking expression is in
skeletal muscles such as those of the hip (5C) and hand-
plate (6A).
Phosphofructokinase liver, Pfkl (MH395, 3A)
This gene is strongly expressed. Transcripts are detected in
liver, muscles, nervous system and the skeletal anlage. Pfkl
transcripts are very abundant in the marginal zone of the
cortex, where they form a patch-like pattern (5C). Other
obvious sites of expression include midbrain, medulla,
spinal cord, dorsal root- and cranial ganglia, thalamus
and hypothalamus. Thymus, pancreas, kidney, adrenal
gland and lung also express Pfkl.
Phosphofructokinase platelet, Pfkp (MH2299, 3A)
The defining feature of Pfkp expression is its restriction to
the central and peripheral nervous systems. In the telen-
cephalon, highly regional expression is seen in the piri-
form cortex (2A) and in scattered neurons of the
vetromedial nucleus of the hypothalamus (4B). In thala-
mus, midbrain, pons and medulla, numerous single neu-
rons express this gene with very prominent expression in
the cranial nerve nuclei (e.g. 3A). Dorsal root ganglia,
motor neurons in the spinal cord, retina and olfactory
bulb also express Pfkp.
Aldolase 1, A isoform, Aldoa (MH1041, 4A)
Aldoa shows strong expression in all muscles, the cardio-
vascular system, kidney, and the axial and appendicular
skeletal elements. In liver, numerous scattered cells also
express Aldoa strongly. Transcripts are seen in ganglia, in
the motor-column of the spinal cord and in the brain,
where elevated expression is detected in the piriform cor-
tex, pons and cranial nerve nuclei.
Aldolase 2 B isoform, Aldob (MH1042, 5B)
Aldob's expression is highly regional; transcripts are found
only in liver and the kidney tubules. There may be weak
Aldob expression in the midgut (4A).BMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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Expression pattern of Isocitrate dehydrogenase 3 (NAD+) alpha, (Idh3a), a representative example of a gene with a stereotypical  energy metabolism pattern (SEMP) Figure 2
Expression pattern of Isocitrate dehydrogenase 3 (NAD+) alpha, (Idh3a), a representative example of a gene with 
a stereotypical energy metabolism pattern (SEMP). Idh3a (MH 965, 4C) is expressed widely in CNS, PNS, muscle, liver, 
kidney, lung, heart, pancreas, intestine, thymus, epithelia covering the alimentary and respiratory tract and whisker follicles. 
Relevant to the definition of SEMP is a relative regional elevation of expression, e.g. in the neocortex (nx), cranial ganglia (cg), 
dorsal root ganglia (drg), spinal cord (sc), heart (h), liver (li), lung (lu), intestine (i), salivary glands (sg) and muscles (m). Further-
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Matrices representing the expression pattern of glycolysis (A) and TCA cycle (B) genes in signature tissues Figure 3
Matrices representing the expression pattern of glycolysis (A) and TCA cycle (B) genes in signature tissues. 
The expression level for each gene is shown in color. Red signifies strong expression; yellow, medium; and blank, weak expres-
sion. In cases where transcripts could not be detected, boxes are shown in blue. The Genepaint set IDs point to the data sets 
from which quantitative assessments were made. Genes showing a SEMP are in bold.BMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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Aldolase 3 C isoform, zebrin II, Aldoc (MH1236, 4A)
Expression of this isoform is strong in the ventricular zone
of neocortex (5B), hippocampus and spinal cord (4B).
Strong expression is also seen in neuroepithelium lining
the floor of the aqueduct and of the fourth ventricle (5A).
In the case of the fourth ventricle, cells exiting the neu-
roepithelium express Aldoc (5A). Weaker Aldoc is seen in
cranial and dorsal root ganglia as well as throughout the
spinal cord. Notably, Aldolase a, b and c collectively consti-
tute a SEMP when superimposed but none of them alone
is a SEMP.
Triosephosphateisomerase, Tpi (MH1224, 4D)
Tpi  is expressed throughout the embryo but signal
strength varies. It is elevated in the ventricular zone of the
cortex, in the pons, medulla, midbrain, lens, liver, heart,
cranial ganglia and choroid plexi. A particular feature of
the expression pattern is the scattered Tpi-positive cells
located at the striatal-cortical interface (2A). In addition,
this gene is expressed in the spinal cord, most strongly in
the motor column (4C). Tpi transcripts are also detected
in muscles, the PNS, piriform cortex, retina, epidermis,
cerebellum, pituitary, lung, facial epithelium, interverte-
bral discs and joints of limbs.
Glyceraldehyde 3-phosphate dehydrogenase spermatogenic, 
Gapdhs (MH1207, 4B)
No expression of Gapdhs is detected at E14.5.
Glyceraldehyde 3-phosphate dehydrogenase, Gapdh (MH2013, 
4C)
The expression pattern of Gapdh is broad with transcripts
seen throughout the embryo except in the axial skeletal
elements, where no expression is detected.
Phosphoglycerate kinase 1, Pgk1 (MH2060, 1D, 5B)
Pgk1 is strongly expressed throughout the integuments,
but Pgk1 transcripts are found in all organs with the excep-
tion of the axial skeleton (4D).
Phosphoglycerate mutase 1, Pgam1 (MH1112, 4C, 5C)
Several tissues show strong Pgam1 expression including
the ventricular zone, piriform cortex, cranial nerve nuclei,
pituitary, olfactory epithelium, retina, dorsal root ganglia,
cranial ganglia, whisker follicles, thymus, salivary glands,
kidney and liver.
Phosphoglycerate mutase 2, Pgam2 (MH2059, 3B)
The strongest Pgam2  expression is seen in the integu-
ments, but expression is ubiquitous with the exception of
the prevertebrae (4B).
Enolase 1, alpha non-neuron enolase 1, Eno1 (MH2056, 3B, 4B)
Eno1 is expressed strongly in the integuments. With the
exception of the prevertebrae, all tissues express Eno1
weakly.
Enolase 2, gamma neuronal enolase2, Eno2 (MH1206)
Eno2 is characterized by strong expression in the CNS, cra-
nial and dorsal root ganglia. Eno2 expression in the CNS,
however, is highly regionalized with positive and negative
tissues intermingling. For example, there is high expres-
sion in the piriform cortex but none in the surrounding
cortical cells (1C). In the neocortex, Eno2 transcripts are
detected in the marginal zone but not elsewhere (5A). In
the pons, transcripts are abundant in the nuclei of the
motor trigeminal nucleus (5D), but the rest of the pons
shows much less expression. In the spinal cord, Eno2
expression is strongest in ventral-most neurons while very
little signal is seen in the roof (5A). Outside the nervous
system, expression of Eno2 is seen in salivary glands, and
weakly in intestine and lung (5D).
Enolase 3, beta muscle enolase 3, Eno3 (MH1229, 4A)
Eno3 is ubiquitously expressed except in the axial skeleton
(3D).
Pyruvate kinase, muscle, Pkm2 (MH1052, 2D, 4A)
Expression of Pkm2 is ubiquitous in the CNS but is ele-
vated in certain structures such as the ventricular zone that
lines the left ventricles and the inferior colliculus of the
midbrain. Many tissues outside the CNS express this gene
with the exception of the prevertebrae. In the liver, most
cells do not express Pkm2 with the exception of blood ves-
sels.
Pyruvate kinase liver and red blood cell, Pklr (MH1218, 3A)
Pklr mRNA is abundant in liver, lung, salivary gland, teeth
primordia and gut (2C). Transcripts of this gene are also
readily detected in the motor column of the spinal cord,
in the olfactory epithelium and in intervertebral discs.
Numerous other sites of expression are observed, but the
signal strength is significantly lower than in the aforemen-
tioned tissues. Pkm2 and Pklr superimposed constitute a
SEMP.
Expression patterns of tricarboxylic acid cycle enzymes
Some of the 20 polypeptide chains catalyzing the 8 TCA
cycle steps form multienzyme complexes (see Fig. 3B).
This adds a new dimension to the analysis of expression
because the components of multisubunit proteins should
be coexpressed. Consequently, they are expected to
exhibit similar expression patterns, which should be read-
ily apparent in an ISH analysis. As discussed above, 12 of
the 20 TCA cycle genes may also exhibit a SEMP. Although
the variability within the SEMP is greater in the TCA cycle
genes than in glycolysis, the stereotypic pattern is stillBMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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observed. Using the same criteria as for glycolysis, matrix
B in Fig. 3 provides a synopsis of expression and high-
lights SEMP results in bold. For each step of the TCA cycle,
at least one gene exhibits a SEMP.
Citrate synthase, Cs (MH1408, 3A, 5A)
This gene is most strongly expressed in whisker follicles,
cranial ganglia, dorsal root ganglia, salivary gland, differ-
entiating neurons of the olfactory bulb and a subset of cra-
nial nerve nuclei. Expression is also detected in liver, lung,
kidney, heart and thymus.
Citrate synthase like, Csl (MH953, 3A, 5A)
This gene is broadly expressed throughout the embryo but
signal strength is elevated in the cranial ganglia, liver,
muscles, kidney, medulla, pons, heart, salivary gland, dor-
sal root ganglia, olfactory bulb, thymus, spinal cord, intes-
tine, neocortex, midbrain and diencephalon. Csl is not
expressed in the axial skeleton or the long bones of the
limbs.
Aconitase 1, Aco1 (MH1441, 3B, 5B)
The Aco1 gene is broadly expressed but stronger expres-
sion is seen in liver, kidney, lung, adrenal gland and sali-
vary gland. Within the nervous systems, Aco1 transcripts
are elevated in forebrain, brain stem, spinal cord, cranial
and dorsal root ganglia.
Aconitase 2, Aco2 (MH1404, 3A, 4A)
Like Aco1, Aco2 is expressed in nearly all tissues. However,
several sites are characterized by regional expression. For
example, elevated expression is seen in the marginal zone
of the neocortex (5C); in the hindbrain, localized expres-
sion is seen in several pontine (5B) and medullary nuclei
(5B), and in the spinal cord, transcript levels are highest
in the motor columns (4A). Dorsal root ganglia are char-
acterized by intermingling of Aco2-positive and negative
neurons (5A).
Isocitrate dehydrogenases complex
The conversion of isocitrate to alpha-ketoglutarate repre-
sents an allosterically regulated, rate-limiting step of the
Krebs cycle. Five genes encoding isocitrate dehydroge-
nases have been identified in mammals (Idh1, 2, 3a, 3b
and 3g). Idh1 (Idpc) encodes a cytosolic enzyme that uses
NADP+ as cofactor and thus is not a Krebs cycle enzyme
proper but has a major role in lipid metabolism [28]. Idh2
(Idpm) also encodes an enzyme that uses NADP+ as cofac-
tor and is located in the mitochondrial matrix. Idh3a,
Idh3b and Idh3g encode enzymes that utilize NAD+ as
cofactor and reside in the mitochondrial matrix. These
three polypeptides form a heterotetramer comprising two
Idh3α subunits, one Idh3β and one Idh3γ subunit [29].
Idh3α has been proposed as the catalytic subunit while
Idh3β and Idh3γ have supporting and regulatory roles
[30]. It would be thus expected that these genes have sim-
ilar expression patterns. Studies with recombinant
polypeptides also suggest that isocitrate dehydrogenase
heteromers are catalytically active only if they contain the
Idh3a subunit [30].
Isocitrate dehydrogenase 1, Idh1 (MH964, 3A, 4C)
Idh1 encodes a cytosolic enzyme that is strongly expressed
in kidney, adrenal gland, intestine, thymus and cartilage.
This gene is weakly expressed in stomach, facial soft tissue,
muscle, lung and liver. Idh1  stands out because of its
strong expression in CNS and PNS. It should be noted that
Idh1 synthesizes alpha-ketoglutarate and NADPH, which
can be utilized by glutamate synthase to generate the neu-
rotransmitter glutamate, perhaps explaining the strong
expression in the developing nervous system.
Isocitrate dehydrogenase 2, Idh2 (MH1299, 1B, 3D)
Mitochondrial enzyme-encoding Idh2 is expressed nearly
ubiquitously but the strongest signal is seen in skeletal
muscles, the developing heart, choroid plexi (3D) and
lens (1B). There is a notable absence of Idh2 expression in
the developing axial and appendicular cartilage (1B).
Isocitrate dehydrogenase 3 (NAD+) alpha, Idh3a (MH965, 4C, 
6A)
Idh3a  is broadly expressed in the CNS with transcripts
being observed in nearly all tissues. Nonetheless, this gene
stands out among the isocitrate dehydrogenases because
of its strong expression in muscles, heart, thymus, intesti-
nal epithelium, liver, CNS, PNS, and developing whisker
follicles. There is a notable absence of expression in the
developing axial and appendicular cartilage, as is typical
for SEMP.
Isocitrate dehydrogenase 3 (NAD+) beta, Idh3b (MH1313, 2A, 
4A)
Isocitrate dehydrogenase 3 (NAD+) gamma, Idh3g (MH1300, 
1D, 4A)
The expression patterns of Idh3b and Idh3g resemble that
of Idh3a, although the intensity is much weaker. Thus,
while Idh3a exhibits a definitive SEMP, this pattern is less
pronounced for the β and γ subunits. The elevated expres-
sion of the α subunit can presumably be rationalized if we
consider the stoichiometric ratios 2α:1β:1γ in the active
enzyme and the implication of the α subunit as the cata-
lytic enzyme, which could potentially drive the complex.
Oxoglutarate dehydrogenase complex
Oxoglutarate dehydrogenase is a mitochondrial enzyme
complex comprising three different subunits (Ogdh, Dld,
Dlst) that converts 2-oxoglutatate into succinyl-CoA and
carbon dioxide. Like pyruvate dehydrogenase, oxoglutar-
ate dehydrogenase forms a large multienzyme complex
and the conversion of 2-oxoglutatate into succinyl-CoABMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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requires the presence of all three subunits. Consequently,
one would predict that Ogdh, Dld and Dlst genes have sim-
ilar expression patterns.
Oxoglutarate dehydrogenase lipoamide, Ogdh (MH1551, 3D)
Dihydrolipoamide S-succinyltransferase, Dlst (MH948, 4A)
Dihydrolipoamide dehydrogenase, Dld (MH962, 4A)
All three genes encoding oxoglutarate dehydrogenase sub-
units show very similar expression patterns, but only Ogdh
has strong SEMP features.
Succinate-coenzyme A ligase complex
Succinate-coenzyme A ligase is a mitochondrial matrix
enzyme that converts succinyl-CoA to succinate and CoA.
It consists of an invariant alpha subunit (encoded by
Suclg1) and a beta subunit that is either ADP (Sucla2) or
GDP-specific (Suclg2).
Succinate-CoA ligase, alpha subunit, Suclg1 (MH1312, 4A)
Succinate-coenzyme A ligase, ADP-forming beta subunit, Sucla2 
(MH1492, 3A, 4A)
Both subunits exhibit the typical energy metabolism
expression pattern with expression in the CNS, PNS, mus-
cles, liver, kidney, gastrointestinal tract, adrenal and sali-
vary glands. There is no expression in axial or limb
cartilage. This stereotypical pattern is somewhat more
pronounced for the ADP-forming beta subunit than for
the alpha subunit.
Succinate-Coenzyme A ligase, GDP-forming beta subunit, 
Suclg2 (MH2300)
Although Suclg2 expression resembles that of Suclg and
Sucla2 in some ways, there are striking differences. Gener-
ally, CNS and PNS show very low Suclg2 expression. The
only exceptions are in the ventricular zone lining the lat-
eral ventricles of the forebrain, the lamina terminalis, the
anterior boundary of the thalamus (4C) and the neuronal
component of the pituitary (4B), where somewhat ele-
vated expression can be seen. Other notable exceptions to
the low expression of Suclg2 in the CNS are the scattered
cells of the amygdala, which express the gene strongly
(6D).
Succinate dehydrogenase complex
This complex consists of four subunits and is located in
the inner mitochondrial membrane. Subunit A (Sdha) is
a flavoprotein while subunit B is an iron-sulfur subunit
(Sdhb). Subunits C and D are integral membrane proteins
(Sdhc, Sdhd).
Succinate dehydrogenase complex, subunit A, flavoprotein, 
Sdha (MH2020, 4A, 5A)
Succinate dehydrogenase complex, subunit B, iron sulfur, Sdhb 
(MH1116, 3B, 4B)
Succinate dehydrogenase complex, subunit C, integral 
membrane protein, Sdhc (MH1427, 3A, 3D)
Succinate dehydrogenase complex, subunit D, integral 
membrane protein, Sdhd (MH1759, 4A)
Since all four polypeptide chains need to be coexpressed
to form an active enzyme, it is not unexpected that the
expression patterns of the four genes are related. There are,
however, quantitative differences in expression level. For
example,  Sdhd  expression in liver is much more pro-
nounced than in other tissues (MH1759, 1B), while the
expression of e.g. Sdhb  is fairly similar everywhere
(MH1116, 1B). Irrespective of such subtle quantitative
differences, all four genes display the stereotypical energy
metabolic enzyme pattern of expression.
Fumarate hydratase 1, Fh1 (MH954, 2D, 4B)
This gene is broadly expressed and its pattern of expres-
sion resembles those of other glycolytic/TCA enzymes,
although the differences in expression levels are less pro-
nounced than those seen for Idh3a (Fig. 2).
Malate dehydrogenases
Malate dehydrogenase 1, NAD+ (cytosolic), Mdh1 (MH1305)
Mdh1 is essential for the malate-aspartate shuttle, but like
Idh1 it is not a component of the TCA cycle.Mdh1  is
expressed in a SEMP-like manner with additional expres-
sion in the facial epithelia (2D).
Malate dehydrogenase 2, NAD+ (mitochondrial), Mdh2 
(MH1434, 3A, 4B)
Mdh2, a TCA cycle component, shows a SEMP expression
pattern. The similarity in expression between Mdh1 and
Mdh2 is critical since these enzymes play a pivotal role in
the malate-aspartate shuttle. Since oxaloacetate cannot
enter the mitochondrion directly, it is first converted by
Mdh1 to malate, which readily enters the mitochondrion
and is then reconverted to oxaloactetate by Mdh2.
Our study covers the expression of glycolysis and TCA
cycle genes in full. At E14.5, at least one isoform of each
step in these pathways shows a SEMP pattern. An excep-
tion to this rule is Aldoa, Aldob and Aldoc, none of which
has a SEMP alone, though together they constitute a
SEMP. A finding that emerges from our analysis of TCA
cycle components is that in cases where the biochemistry
depends on a multisubunit complex, the transcripts of at
least one subunit show a SEMP while the other subunits
may have uniform expression (Fig. 3B).
Some transcripts of glycolytic pathway genes are expressed
highly regionally, such as hexokinase isoform 4 (Gck). ThisBMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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indicates a regional function more specialized than energy
production. Northern blot data and ISH analysis of post-
natal and adult tissues detect Gck mRNA in the lateral
hypothalamic area and in the arcuate, ventromedial, dor-
somedial and paraventricular nuclei [31,32]. It has been
suggested that Gck-positive neurons are "glucose-sensing
neurons" that respond to high glucose concentration [32].
The expression pattern of Gck at E14.5 suggests that a glu-
cose-sensing mechanism has become established by this
stage in development, since our data demonstrate Gck
mRNA in the precursors of the above-mentioned hypoth-
alamic nuclei.
Miki et al. [33] analyzed expression patterns in 49 differ-
ent mouse embryonic and adult tissues using microarrays
containing 18,816 mouse cDNAs. These authors found
that genes encoding enzymes catalyzing glycolytic reac-
tions that are closely linked have similar expression pat-
terns. They also found that transcripts from key regulatory
genes exhibited tissue specificity. To a large extent our
data point in the same direction, although the data are
obviously different in nature.
Carbonic anhydrases
In mouse, 16 CA family members have been identified, 13
of which are CAs proper (see Background). Fifteen of the
16 members of this gene family were analyzed for expres-
sion at E14.5. The 15 RNA probes hybridized ranged
between 900 and 1,600 nucleotides in length. For most of
the CAs we were able to design templates, and hence
probes, that had no sequence homology to any other fam-
ily member. However, there was homology of ~ 80% in a
few cases, ranging from 69 to 117 nucleotides (see Table
3). The highest homology over the longest stretch of DNA
was seen between the Car2 probe and Car3 mRNA (77%
over 168nts; Table 3). Despite this homology, no cross-
hybridization occurred. For example, Car2 was strongly
expressed in blood vessels of the brain and in the lung
(MH1443), but no such expression was seen in these tis-
sues in sections hybridized with authentic Car3 riboprobe
(MH1651).
Expression patterns of carbonic anhydrases
Carbonic anhydrase 1, Car1 (MH1800)
Strongly expressing cells are scattered throughout the liver
(1A) and weak expression approaching background level
is seen in various embryonic tissues.
Carbonic anhydrase 2, Car2 (MH1443)
Car2 expression is regional. Major sites of expression are
lung mesenchyme surrounding the bronchi, liver, capil-
laries distributed throughout the embryo, choroid plexi
and cochlea (5B). In contrast to Car1, expression of Car2
is widespread.
Carbonic anhydrase 3, Car3 (MH1651)
Car3, which encodes a cytosolic isozyme, is expressed
with a high degree of tissue specificity. Striated muscles,
facial cartilage (2B), ureter (3B) and scattered neurons in
dorsal root ganglia express Car3 strongly. In liver, Car3
expression is widespread, resembling that of Car2.
Carbonic anhydrase 4, Car4 (MH1444)
Expression of this gene, which encodes a protein
anchored to the plasma membrane, is confined to devel-
oping glomeruli (5A) and weakly-expressing cells scat-
tered throughout the CNS, presumably representing
blood vessels. Car4 may be an excellent marker for embry-
onic kidney.
Carbonic anhydrase 5a, mitochondrial, Car5a (MH2294)
Carbonic anhydrase 5b, mitochondria, Car5b (MH1283)
No expression of these two mitochondrial enzymes is
detected in the mouse embryo at E14.5.
















Car1 77/98 (78%)§ 78/96 (81%) 80/102 (78%)
Car2 77/98 (78%) 130/168 (77%) 84/112 (75%) 133/185 (71%)
Car5b 84/112 (75%) 117/149 (78%) 
207/284 (72%)
Car5a 117/149 (78%) 
194/266 (72%)
Car7 69/85 (81%)
Car11 82/106 (77%) 82/106 (77%)
Car13 80/102 (78%)
# GenBank accession number of reference sequence
* Ensembl transcript ID
§Homology of aligned fragments using bl2seq (template/cDNA) and percent homologyBMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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Carbonic anhydrase 6, Car6 (MH2295)
No expression is detected for the Car6 gene in the E14.5
mouse embryo.
Carbonic anhydrase 7, Car7 (MH2296)
This cytoplasmic enzyme shows weak to medium expres-
sion throughout the embryo.
Carbonic anhydrase 8, Car8 (MH2175)
Expression of this CA-RP is highly regional. Transcripts are
abundant in cerebellum (2D), thyroid (4D), clavicle pri-
mordium, intestine and stomach (2D). Car8  is also
detected in heart, dorsal aorta (4C), bronchi (5A), salivary
glands and the cortical region of the kidneys (3C).
Carbonic anhydrase 10, Car10 (MH2174)
Weak to medium expression can be seen scattered
throughout the embryo, although there are also Car10-
negative tissues such as the axial skeleton (3D). Some-
what elevated expression can be seen in scattered neurons
of the CNS (3D) and PNS (2D) and in the heart (4D).
Carbonic anhydrase 11, Car11 (MH2291)
Car11 is expressed in the cranial and dorsal root ganglia,
olfactory bulb, striatum, amygdala and the midbrain. Par-
ticularly striking is the enrichment of these CA-RP tran-
scripts in the boundary cap of the cranial (5D) and dorsal
root ganglia (5C).
Carbonic anhydrase 12, Car12 (MH2120)
This is another example of a regionally-expressed CA
gene. Choroid plexi, salivary glands and facial as well as
ventral integument, including the whisker follicles,
express this transmembrane protein strongly (2D). A
medium level of expression is detected in kidney, lung,
cerebral cortex, hindbrain, spinal cord and the PNS.
Carbonic anhydrase 13, Car13 (MH2292)
Car13 is strongly expressed in the inner ear and cochlea
(3A). However, the most striking expression site of this
gene is at a muscle fiber bundle located posterior to the
submandibular gland (2D). Meninges covering the ven-
tral delineation of the hypothalamus and pons exhibit
attenuated expression (2C).
Carbonic anhydrase 14, Car14 (MH1292)
This gene is expressed exclusively in the pigment layer of
the retina (1A) and choroid plexi (3C).
Carbonic anhydrase 15, Car15 (MH2293)
Strong expression is localized in cells scattered through-
out the dorsal root ganglia (4D), dorsal spinal cord, pons,
tegmentum and inferior colliculus (3D). A few other
structures (bronchi, cornea and lens, for example) also
express the gene, but only weakly.
Because carbonic anhydrases catalyze a ubiquitous reac-
tion, one might have predicted them to be widely
expressed. However, this was not the case, since half the
CA genes showed a considerable degree of regionaliza-
tion. Although there have been few reports about expres-
sion in the developing mouse embryo, we found our
results to be generally consistent with published CA data.
At comparable embryonic stages, transcripts of Car3 were
reported in skeletal muscle and ureter [34], and Car8
mRNA was seen in cerebellum, gut, kidney, lung and heart
[35,36]. The expression of Car12 in choroid plexus and
kidney was also consistent with previous reports [37]. The
specific expression sites reported here for Car10, Car11,
Car13  and  Car15  had not been described previously,
although expression had been reported in whole embryos
and in adult tissues using Northern blots and RT-PCR
[9,11,36,38]. MA data for Car1, 14 and 15 showed them
to be absent, but we were able to reveal definite and
regionalized expression of these genes using ISH. MA
analysis was apparently not sufficiently sensitive to detect
mRNAs that are confined to a few cells representing a
minute fraction of the total tissue from which the RNA
was extracted.
The developmental expression we report here is also con-
sistent with the expression described in adult tissues.
Expression of embryonic Car1 [39], 4 [40], 10, 11 [36], 12
[38] and 14 [41] presumably presages that in the adult.
For example, adult Car 1 protein is abundant in erythro-
cytes [5,39]. The expression we describe for Car1 in the
embryonic liver presumably marks sites of hematopoiesis
because Car1 expression resembles that of hematopoietic
maturation-associated  c-myb  (MH766) and the hepato-
cyte differentiation molecular marker Hnf4α  (MH521)
[42,43]. Furthermore, Car1 was recently suggested as a tar-
get of the transcription factor c-Myb [44]. Embryonic
expression of Car3 in muscles and Car4 in glomeruli and
blood vessels of the CNS presumably presages adult
expression in these tissues [18,40]. In adult rat, Car4 has
been proposed as an immunohistochemical marker for
the blood-brain barrier and is thought to play an impor-
tant role in CO2/HCO3
- homeostasis in the brain [40].
Expression in blood vessels of the CNS is already apparent
in the E14.5 embryo, suggesting that CO2/HCO3 
- conver-
sion is established early in development. Car5 has been
reported as responsible for supplying HCO3 
- in gluconeo-
genesis and ureagenesis, pathways restricted to liver mito-
chondria [45,46]. Consistent with this, Car5 protein is
only detected in adult liver [47]. Despite the substantial
activities of all gluconeogenesis enzymes, gluconeogene-
sis itself is reported to proceed at very low rates in fetal
hepatocytes and to be triggered by birth itself [48]. This is
consistent with our inability to detect Car5 in the embryo.
Finally, Car6 is normally secreted into saliva and milk
[17,49]; there is no embryonic expression of Car6, per-BMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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haps because these fluids are not yet produced at E14.5,
although salivary and mammary gland primordia are
present at this stage of development.
Conclusion
The results presented here constitute the first comprehen-
sive description of the expression of all enzymes involved
in glycolysis and the TCA cycle. Global studies such as this
are especially useful for revealing higher degree-associa-
tions. We provide evidence for a Stereotypical Energy
Metabolism Pattern (SEMP) of expression (Fig. 3). Of the
total of 42 genes encoding either a glycolysis or a TCA
cycle enzyme, 21 exhibited a SEMP. The defining future of
a SEMP is expression in 22 "signature tissue". For the
majority of genes classified as SEMP, expression in all of
the 22 signature tissue is observed. Examples of excep-
tions are Fh1, Sucla and Hk1. The existence of a SEMP
raises the possibility that many glycolytic and TCA cycle
genes may be regulated in a coordinated fashion. Whether
this is also true for other metabolic pathways, such as
amino acid or protein syntheses, remains to be seen. Our
study also makes the point that even so-called housekeep-
ing genes, although quite broadly expressed, may vary sig-
nificantly among tissues in levels of expression.
Kinases have received much attention during recent dec-
ades owing to their physiological importance and their
high potential as drug targets. Initial efforts in the study of
the kinome have concentrated on three specific aspects:
(i) the identification of novel kinases, (ii) the identifica-
tion of ligands to known kinases, and (iii) the complete
characterization of signal transduction to map the bio-
chemical pathways of the kinome fully [23,50]. As more
data become available, so systematic and interactive data-
bases arise, similar to that presented here for managing
gene expression data [51,52]. Thus, our study comple-
ments the information gathered by the kinome-research
community. At the same time, current trends in kinome
research are switching towards structure prediction, struc-
ture analysis (to identify key amino acid residues) and
gene expression profiling for eventual comparison in
mutant or disease conditions [51,52]. The expression
analysis of 190 kinases reported here sets the ground and
illustrates the feasibility of a high-throughput expression
analysis of the kinome, and provides the expression pat-
terns for over one third of the mouse kinome.
With this study we also corroborate the practicality of
high-throughput ISH. The usefulness of comprehensive
data sets is even more apparent when all results are acces-
sible through the Genepaint database [4]. Contrary to the
common expectation that enzymes encoded by "house-
keeping" genes will be widely expressed, almost half the
carbonic anhydrase gene family shows a regionalized
expression pattern and a number of them are so highly
regionalized that they are suitable as tissue-specific mark-
ers. Hence these enzymes show regional diversity in
expression, as reported for transcription factors [53] and
growth factors [19], both of which are recognized key
components of biological regulation.
In summary, this study greatly increases our general
knowledge of the expression patterns of many genes that
encode enzymes catalyzing various types of metabolic
reactions. Although the data are from E14.5 embryos we
believe that information collected at this stage serves as a
suitable predictor and starting point for the elucidation of




See Yaylaoglu et al. [19] for procedures.
RNA probe synthesis
Probe synthesis was carried out as previously described
[19]. The quantity and quality of riboprobes were assessed
using the Bioanalyzer (Agilent Technologies, Waldbronn,
Germany).
Tissue collection, sectioning and in situ hybridization
All animal experiments were conducted in compliance
with the German Law on Animal Welfare. Procedures for
tissue collection, sectioning and ISH followed those
described in Yaylaoglu et al. [19].
Imaging and data management
Standard protocols as in Yaylaoglu et al[19] were fol-
lowed. Images were acquired with a scanning microscope
equipped with a 10× objective (NA 0.4) and a CCD cam-
era programmed to capture 125 magnified frames per
embryo section. Individual images were used to compose
a mosaic image. Image resolution: 1.6 μm/pixel. Images
were converted to Kodak FlashPix, which together with





ISH in situ hybridization
HT-ISH High-throughput in situ hybridization
MA Microarray
SEMP Stereotypical energy metabolism patternBMC Genomics 2007, 8:232 http://www.biomedcentral.com/1471-2164/8/232
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TCA Tricarboxylic acid cycle
CNS Central nervous system
PNS Peripheral nervous system
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